MedPath

Sodium glycerophosphate

Generic Name
Sodium glycerophosphate
Brand Names
Glycophos, Olimel, Periolimel
Drug Type
Small Molecule
Chemical Formula
C3H7Na2O6P
CAS Number
1334-74-3
Unique Ingredient Identifier
G43E72677U

Overview

Sodium glycerophosphate is one of several glycerophosphate salts. It is used clinically to treat or prevent low phosphate levels . Glycerophosphate is hydrolyzed to inorganic phosphate and glycerol in the body . The extent of this reaction is dependent on the activity of serum alkaline phosphatases.

Background

Sodium glycerophosphate is one of several glycerophosphate salts. It is used clinically to treat or prevent low phosphate levels . Glycerophosphate is hydrolyzed to inorganic phosphate and glycerol in the body . The extent of this reaction is dependent on the activity of serum alkaline phosphatases.

Indication

Sodium glycerophosphate is indicated for use as a source of phosphate in total parenteral nutrition . It is used in combination with amino acids, dextrose, lipid emulsions, and other electrolytes.

Associated Conditions

No associated conditions information available.

FDA Approved Products

Kabiven
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:147 mg in 100 mL
Approved: 2023/08/02
NDC:63323-712
Perikabiven
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:105 mg in 100 mL
Approved: 2023/08/07
NDC:63323-714
Glycophos
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:216 mg in 1 mL
Approved: 2019/01/16
NDC:63323-241

Singapore Approved Products

GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml
Manufacturer:FRESENIUS KABI NORGE AS
Form:INJECTION
Strength:216 mg/ml
Online:Yes
Approved: 2002/04/01
Approval:SIN11858P
SmofKabiven Emulsion for Infusion
Manufacturer:Fresenius Kabi AB, Fresenius Kabi Austria GmbH
Form:INJECTION, EMULSION
Strength:4.18g /1000ml
Online:Yes
Approved: 2013/01/08
Approval:SIN14286P
KABIVEN PERIPHERAL EMULSION FOR INFUSION
Manufacturer:FRESENIUS KABI AB, FRESENIUS KABI AUSTRIA GMBH
Form:INJECTION
Strength:1.0 g/l
Online:Yes
Approved: 2001/11/16
Approval:SIN11718P
OLICLINOMEL N7-1000 E EMULSION FOR INFUSION
Manufacturer:BAXTER SA, Ajinomoto North America Incorporated (Intermediate)
Form:EMULSION
Strength:2.14 g/l
Online:Yes
Approved: 2004/05/06
Approval:SIN12539P
PERIOLIMEL N4E Emulsion for Infusion
Manufacturer:Ajinomoto Health & Nutrition North America Inc. (Intermediate), Baxter S.A
Form:EMULSION
Strength:1.91g/L
Online:Yes
Approved: 2023/10/20
Approval:SIN16888P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath